O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

NCT00961220 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

17

Enrollment

NIH

Sponsor class

Conditions

Recurrent Primary Cutaneous T-Cell Non-Hodgkin Lymphoma
Stage I Mycosis Fungoides and Sezary Syndrome AJCC v7
Stage II Mycosis Fungoides and Sezary Syndrome AJCC v7

Interventions

DRUG: Carmustine
OTHER: Laboratory Biomarker Analysis
DRUG: O6-Benzylguanine

Sponsor

National Cancer Institute (NCI)